Cargando…

Cervical human papillomavirus genotypes in a high HIV setting: A scoping review of a decade of human papillomavirus epidemiological research in Botswana

Cervical cancer burden is still high in low- and middle-income countries, including Botswana. Persistent human papillomavirus (HPV) infection is the leading cause of cervical cancer. Accurate knowledge of HPV diversity associated to cervical cancer in sub-Saharan Africa may provide accurate understa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tawe, Leabaneng, Ramatlho, Pleasure, Ketlametswe, Rebecca, Koobotse, Moses, Robertson, Erle S., Grover, Surbhi, Ramogola-Masire, Doreen, Paganotti, Giacomo M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729273/ https://www.ncbi.nlm.nih.gov/pubmed/36507502 http://dx.doi.org/10.3389/fmed.2022.1020760

Ejemplares similares

Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya
por: Tawe, Leabaneng, et al.
Publicado: (2022)

Promoter Hypermethylation Analysis of Host Genes in Cervical Cancer Patients With and Without Human Immunodeficiency Virus in Botswana
por: Tawe, Leabaneng, et al.
Publicado: (2021)

Molecular detection of human papillomavirus (HPV) in highly fragmented DNA from cervical cancer biopsies using double-nested PCR
por: Tawe, Leabaneng, et al.
Publicado: (2018)

Preliminary survey on Anopheles species distribution in Botswana shows the presence of Anopheles gambiae and Anopheles funestus complexes
por: Tawe, Leabaneng, et al.
Publicado: (2017)

Human cytochrome P450 2B6 genetic variability in Botswana: a case of haplotype diversity and convergent phenotypes
por: Tawe, Leabaneng, et al.
Publicado: (2018)

Human papillomavirus prevalence in male and female university students in Gaborone, Botswana
por: Ramogola-Masire, Doreen, et al.
Publicado: (2022)

Characterization of HPV subtypes in invasive cervical cancer in Botswana patients using a pan-pathogen microarray technology
por: Grover, Surbhi, et al.
Publicado: (2023)

Invasive cervical cancers from women living in the United States or Botswana: differences in human papillomavirus type distribution
por: Ermel, Aaron, et al.
Publicado: (2014)

Past and current biological factors affecting malaria in the low transmission setting of Botswana: A review
por: Bango, Zackary Austin, et al.
Publicado: (2020)

Mosquito vector diversity and abundance in southern Botswana, in a global context of emerging pathogen transmission
por: Makate, Ntebaleng, et al.
Publicado: (2022)

Comparison of the AmpFire(®) Multiplex HPV Assay to the Xpert(®) HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: A pragmatic performance evaluation
por: Moyo, Sikhulile, et al.
Publicado: (2023)

Comparison of the AmpFire® Multiplex HPV Assay to the Xpert® HPV Assay for detection of human papillomavirus and cervical disease in women with human immunodeficiency virus: a pragmatic performance evaluation
por: Moyo, Sikhulile, et al.
Publicado: (2023)

Availability of WHO Essential Medicines for Cancer Treatment in Botswana
por: Martei, Yehoda M., et al.
Publicado: (2018)

Type distribution of human papillomavirus in HIV-infected women with cervical intraepithelial neoplasia (CIN) stages 2 and 3 in Botswana
por: Ramogola-Masire, Doreen, et al.
Publicado: (2010)

Factors Related to Advanced Stage of Cancer Presentation in Botswana
por: Anakwenze, Chidinma, et al.
Publicado: (2018)

Cervical cancer screening in HIV-endemic countries: An urgent call for guideline change
por: Grover, Surbhi, et al.
Publicado: (2023)

Breast Cancer Pathology Turnaround Time in Botswana
por: Martei, Yehoda M., et al.
Publicado: (2017)

Gynecologic Cancer: New and Follow-Up Patient Appointments in Botswana During the COVID-19 Pandemic
por: Davey, Sonya, et al.
Publicado: (2021)

Support for lowering cervical cancer screening age to 25 for women living with HIV: retrospective cross-sectional programmatic data from Botswana
por: Ramogola-Masire, Doreen, et al.
Publicado: (2022)

The role of CYP2B6 516G>T polymorphism on efavirenz/nevirapine toxicity. Implications on treatment outcomes: Lessons from Botswana
por: Maseng, Monkgomotsi J., et al.
Publicado: (2022)

Neoadjuvant chemotherapy and less invasive surgery for the management of early stage cervical cancer: A brief report from Botswana
por: Grover, Surbhi, et al.
Publicado: (2022)

Adherence to screening appointments in a cervical cancer clinic serving HIV-positive women in Botswana
por: Barchi, Francis, et al.
Publicado: (2019)

Multidisciplinary Gynecologic Oncology Clinic in Botswana: A Model for Multidisciplinary Oncology Care in Low- and Middle-Income Settings
por: Grover, Surbhi, et al.
Publicado: (2017)

A Cross-Sectional Study of HPV Vaccine Acceptability in Gaborone, Botswana
por: DiAngi, Yumi Taylor, et al.
Publicado: (2011)

Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana
por: Maseng, Monkgomotsi J, et al.
Publicado: (2021)

Building research capacity through programme development and research implementation in resource-limited settings - the Ipabalele study protocol: observational cohort studies determining the effect of HIV on the natural history of cervical cancer in Botswana
por: Grover, Surbhi, et al.
Publicado: (2019)

Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana
por: MacDuffie, Emily, et al.
Publicado: (2021)

Clinical and sociodemographic factors associated with late stage cervical cancer diagnosis in Botswana
por: Friebel-Klingner, Tara M., et al.
Publicado: (2021)

Explaining disparities in oncology health systems delays and stage at diagnosis between men and women in Botswana: A cohort study
por: Iyer, Hari S., et al.
Publicado: (2019)

Prevalence of oncogenic human papillomavirus genotypes in patients diagnosed with anogenital malignancies in Botswana
por: Rantshabeng, Patricia S., et al.
Publicado: (2017)

Evaluating the geographic distribution of cervical cancer patients presenting to a multidisciplinary gynecologic oncology clinic in Gaborone, Botswana
por: Friebel-Klingner, Tara M., et al.
Publicado: (2022)

Use of mobile telemedicine for cervical cancer screening of HIV-positive women in Gaborone, Botswana
por: Gormley, Rachel H, et al.
Publicado: (2010)

Distance to Multidisciplinary Team Clinic in Gaborone, Botswana, and Stage at Cervical Cancer Presentation for Women Living With and Without HIV
por: Friebel-Klingner, Tara M., et al.
Publicado: (2022)

Stage and outcomes of invasive cervical cancer patients in Botswana: A prospective cohort study from 2013 to 2020
por: Grover, Surbhi, et al.
Publicado: (2022)

Acceptability and Feasibility of Sexually Transmitted Infection Testing and Treatment among Pregnant Women in Gaborone, Botswana, 2015
por: Wynn, Adriane, et al.
Publicado: (2016)

Cervical Cancer in Botswana: Current State and Future Steps for Screening and Treatment Programs
por: Grover, Surbhi, et al.
Publicado: (2015)

Bridging the Gap Between Pilot and Scale-Up: A Model of Antenatal Testing for Curable Sexually Transmitted Infections From Botswana
por: Wynn, Adriane, et al.
Publicado: (2022)

Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications
por: Ermel, Aaron, et al.
Publicado: (2016)

Patient perspectives on delays in cervical cancer screening and follow-up care in Botswana: a mixed methods study
por: Rendle, Katharine A., et al.
Publicado: (2022)

A root-cause analysis of maternal deaths in Botswana: towards developing a culture of patient safety and quality improvement
por: Madzimbamuto, Farai D, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_2fckjpt11khrae0u19nld0kf18